PROTAGENIC THERAPEUTICS INC (PTIX) Stock News

USA - NASDAQ:PTIX - US74365N3017 - Common Stock

4.35 USD

-0.02 (-0.46%)

Last: 9/23/2025, 8:05:21 PM

4.47 USD

+0.12 (+2.76%)

After Hours: 9/23/2025, 8:05:21 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

PTIX Latest News, Press Relases and Analysis

All

Press Releases

a month ago - By: ACCESS Newswire

Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance

a month ago - By: Benzinga - Mentions: AEMD CANF OM EVOK ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

a month ago - By: Benzinga

Protagenic Therapeutics (PTIX) Shares Surge On Clinical Trial Progress

a month ago - By: ACCESS Newswire

Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders

4 months ago - By: Yahoo Finance - Mentions: LMT NVO DHI CMG

Protagenic & Phytanix Merge in All-Stock Move, Sparking Retail Frenzy

4 months ago - By: Halper Sadeh LLC - Mentions: INZY TXNM NYSE

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INZY, TXNM, SVT, PTIX on Behalf of Shareholders

4 months ago - By: Brodsky & Smith LLC - Mentions: INZY TXNM NYSE

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)

4 months ago - By: ACCESS Newswire

Protagenic Therapeutics Receives $3.1 Million from Recent Warrant Activity

4 months ago - By: Stocktwits - Mentions: VXF NFLX JPM

Protagenic Therapeutics Merges With Phytanix Bio In All-Stock Deal: Retail Turns Extremely Bullish

4 months ago - By: Halper Sadeh LLC

PTIX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Protagenic Therapeutics, Inc. Is Fair to Shareholders

4 months ago - By: Brodsky & Smith LLC - Mentions: TXNM SVT INZY BMRN

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Inozyme Pharma, Inc. (Nasdaq – INZY), TXNM Energy, Inc. (NYSE - TXNM), Servotronics, Inc. (NYSE American - SVT), Protagenic Therapeutics, Inc. (Nasdaq – PTIX)